These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial. Sieb JP; Köhler W Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605 [TBL] [Abstract][Full Text] [Related]
6. Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case. Singh G; Hodgson T; Clarke DE Perm J; 2017; 21():15-240. PubMed ID: 28080955 [TBL] [Abstract][Full Text] [Related]
8. Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis. Wacks I; Oster JR; Pérez GO; Kett DH Am J Kidney Dis; 1990 Jul; 16(1):76-9. PubMed ID: 2368710 [No Abstract] [Full Text] [Related]
9. Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials. Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Werneck LC; Scola RH Arq Neuropsiquiatr; 2020 Mar; 78(3):179-181. PubMed ID: 32215460 [TBL] [Abstract][Full Text] [Related]
10. Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis. Rostedt A; Stålberg E Neurology; 2004 Mar; 62(5):835-6. PubMed ID: 15007152 [No Abstract] [Full Text] [Related]
11. [Pro-arrhythmia effect of pyridostigmine. Apropos of a case]. Leenhardt A; Thomas O; Haouala H; Benaïm R; Maison-Blanche P; Cauchemez B; Haguenau M; Coumel P; Slama R Arch Mal Coeur Vaiss; 1992 Dec; 85(12):1853-6. PubMed ID: 1306628 [TBL] [Abstract][Full Text] [Related]
12. Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis. Voon YC; Yahya WN; Hasan S; Ibrahim NM Mov Disord; 2010 Jul; 25(9):1299-300. PubMed ID: 20629121 [No Abstract] [Full Text] [Related]
13. Malabsorption of pyridostigmine in patients with myasthenia gravis. Cohan SL; Dretchen KL; Neal A Neurology; 1977 Mar; 27(3):299-301. PubMed ID: 557769 [TBL] [Abstract][Full Text] [Related]
15. Coexistence of Parkinson's disease and myasthenia gravis: a case report. Kao KP; Kwan SY; Lin KP; Chang YC Clin Neurol Neurosurg; 1993 Jun; 95(2):137-9. PubMed ID: 8344012 [TBL] [Abstract][Full Text] [Related]
16. Renal clearance of pyridostigmine in patients with myasthenia gravis. Chan K; Calvey TN Eur Neurol; 1977; 16(1-6):69-72. PubMed ID: 615720 [TBL] [Abstract][Full Text] [Related]
17. Plasma pyridostigmine levels in myasthenia gravis. White MC; De Silva P; Havard CW Neurology; 1981 Feb; 31(2):145-50. PubMed ID: 7193298 [TBL] [Abstract][Full Text] [Related]
18. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. Tripathi M; Kaushik S; Dubey P J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228 [TBL] [Abstract][Full Text] [Related]